跳至主要内容
临床试验/EUCTR2012-001496-36-AT
EUCTR2012-001496-36-AT进行中(未招募)1 期

Multiple-dose pharmacokinetics of ampicillin / sulbactam and amoxicillin / clavulanic acid during haemodialysis in longterm haemodialysis patients - AMPISUL/AMOXICLAV-HD_V1.4

Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme0 个研究点目标入组 16 人开始时间: 2013年6月25日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • a)Age >18 years
  • b)Suspected or proven bacterial infection requiring parenteral antibiotic therapy.
  • c)Organ replacement therapy (HD)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 12
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 4

排除标准

  • a)Known hypersensitivity to ampicillin / sulbactam, amoxicillin / clavulanic acid or other beta-lactames, or severe hypersensitivity (anaphylactic reaction) to beta-lactam antibacterial agents.
  • b)An expected survival of less than two days.
  • c)Known pregnancy
  • d)Co-administration of one of the following drugs:
  • -probenecid
  • which cannot be discontinued for the duration of the study
  • e)Ampicillin / sulbactam respectively amoxicillin / clavulanic acid as monotherapy for resistant species or fungal infections.
  • f)Other reasons opposing the study participation on the discretion of the investigators.

研究者

发起方
Medizinische Universität Wien, Universitätsklinik für Innere Medizin I, Klinische abteilung für Infektionen und Tropenme

相似试验